Viva Biotech Holdings's total assets for Q4 2024 were ¥7.05B, a decrease of -1.80% from the previous quarter. HK:1873 total liabilities were ¥3.23B for the fiscal quarter, a -4.26% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.